Healthline
October 2, 2023
Share on PinterestThe FDA has updated the label of Ozempic to include blocked intestines among the potential side effect of the drug. Jaap Arriens/NurPhoto/Getty Images The […]
October 2, 2023
Share on PinterestSmall bursts of physical activity can help you stay healthy and decrease mortality risk. ljubaphoto/Getty Images A new study found that people may be […]
September 30, 2023
Share on PinterestHealth experts are raising concerns about the amount of water actor Chris Pratt is said to drink daily as a part of his intense […]
September 30, 2023
Share on PinterestNew research suggests people with cannabis use disorder may have a significantly higher risk of cardiovascular disease. Geoffroy Van Der Hasselt/AFP/Getty Images A new […]
Medscape
October 3, 2023
TOPLINE: Loneliness is associated with a higher risk of developing Parkinson disease (PD) across demographic groups and independent of other risk factors, data from nearly 500,000 […]
October 3, 2023
HAMBURG, Germany ― Once-weekly tirzepatide (Mounjaro, Lilly) added to insulin glargine resulted in greater reductions in A1c along with more weight loss and less hypoglycemia compared […]
October 3, 2023
TOPLINE: Levetiracetam is more effective than is lamotrigine for initial monotherapy in female patients with juvenile myoclonic epilepsy (JME) but not for those with other idiopathic […]
October 3, 2023
PARIS — Multicancer early detection blood (MCED) tests are the focus of intensive development. What techniques do these tests use? What potential do they show? Suzette […]
FDA
October 3, 2023
Notice to Industry: Bioresearch Monitoring Information System (BMIS) Data In order to foster transparency and encourage information sharing within the clinical research community, FDA’s Center for […]
October 2, 2023
Summary Company Announcement Date: October 02, 2023 FDA Publish Date: October 02, 2023 Product Type: Drugs Reason for Announcement: Recall Reason Description Potential Presence of Glass […]
October 2, 2023
Summary Company Announcement Date: September 29, 2023 FDA Publish Date: October 02, 2023 Product Type: Drugs Reason for Announcement: Recall Reason Description Potential Contamination with Microbacterium […]
October 2, 2023
Acetadote (acetylcysteine) Generic products containing acetylcysteine Overdose FDA is evaluating the need for regulatory action. Aromatase inhibitors Arimidex (anastrozole) Aromasin (exemestane) Femara (letrozole) Generic products containing […]
